Guardian Therapeutics Inc is an independent, family- and employee-owned biotech enterprise established in 2017 with its headquarters in the United States. The company specializes in the discovery and development of aptamer therapeutics. Their dedication to cutting-edge biotechnology has attracted significant attention, with their last recorded investment standing at an impressive $20.00M, secured through a Venture Round investment on 14 August 2018.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $20.00M | - | 14 Aug 2018 | |
| Venture Round | $10.00M | - | 08 Feb 2018 |
No recent news or press coverage available for Guardian Therapeutics Inc.
We care about your data, and we'd love to use cookies make your experience better.
